CRVS icon

Corvus Pharmaceuticals
CRVS

Upgrade to unlock
Buy
Hold
Sell

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$32
86% upside
High target

4 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Jefferies
Jefferies
Roger Song
0% 1-yr CRVS win rate
22 Jan ‘26 1 month ago
Oppenheimer
Oppenheimer
Jeff Jones
33% 1-yr CRVS win rate
21 Jan ‘26 1 month ago
Barclays
Barclays
Etzer Darout
50% 1-yr CRVS win rate
21 Jan ‘26 1 month ago
HC Wainwright & Co
HC Wainwright & Co
Sean Lee
100% 1-yr CRVS win rate
20 Jan ‘26 1 month ago